Is The Hain Celestial Group (HAIN) the Best Organic Food Stock to Buy According to Billionaires?
We recently published a list of 10 Best Organic Food Stocks to Buy According to Billionaires. In this article, we are going to take a look at where The Hain Celestial Group, Inc. (NASDAQ:HAIN) stands against other best organic food stocks to buy according to billionaires.
According to a report by Mordor Intelligence, the organic food and beverages market has a size of $184.87 billion as of 2025. It is expected to grow at a compound annual growth rate (CAGR) of 6.02% between 2025 and 2030, reaching $247.63 billion at the end of the forecast period. At present, North America is the largest market for the sector. However, Asia Pacific takes the lead as the fastest growing.
The primary cause behind the growth of the global organic food and beverage market is the increasing adoption of natural and healthy food and beverage options by consumers. Consumers are exhibiting growing inclination and awareness towards the health benefits of organic food products, which is continually acting as the primary stimulus for this industry.
READ ALSO: 12 Best Cruise Stocks to Buy According to Hedge Funds and 14 Best Farmland and Agriculture Stocks Buy Now.
Published by the Research Institute of Organic Agriculture (FiBL) and IFOAM—Organics International, the 25th edition of the yearbook 'The World of Organic Agriculture' shows that the organic farming sector is undergoing significant growth and expansion. It reported that the area under organic management reached around 96.4 million hectares by the end of 2022, reflecting a significant 26.6% growth compared to the previous year. This translates to an expansion of 20.3 million hectares.
The report also showed that the United States took the lead as the largest market in the sector, valued at around EUR 56.6 billion in 2022. Germany followed close behind at EUR 15.3 billion, while China took the third spot at EUR 12.4 billion. The United States and Canada underwent growth in retail sales in the sector, reflecting increases of 4.4% and 9.7%, respectively. These trends show that consumers are increasingly showing interest in organic products, and health consciousness and awareness are supporting demand in North America.
However, these trends are not concentrated in North America alone. The report showed that expansion in organic farming areas occurred across all continents, bringing to life a global trend towards organic food intake and sustainable agricultural practices. The number of organic farmers also rose globally, increasing to 4.5 million in 2022 and reflecting an approximately 26% rise from 2021.
In this article, we first sifted through ETFs and financial media reports to compile a preliminary list of stocks. We then examined Insider Monkey's exclusive database of billionaire stock holdings to select the 10 best organic food stocks with the most billionaire investors. These billionaires are founders or managers of some of the world's leading hedge funds and companies.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).
Two hands crunching into a bag of the company's organic vegetable chips.
Number of Billionaire Investors: 9The Hain Celestial Group, Inc. (NASDAQ:HAIN) is a prominent US-based company specializing in natural and organic foods, as well as personal care products and more. It operates in over 75 countries and has a brand portfolio that includes Terra Chips, Garden Veggie Snacks, Garden of Eatin' snacks, Hartley's Jelly, Joya and Natumi plant-based beverages, and others. Its customer base generally includes supermarkets, natural food stores, specialty and natural food distributors, mass-market, and club stores.
Although the company's organic net sales dropped 7% in fiscal Q2 2025, it generated free cash flow worth $25 million and continued to progress on its net debt, slashing it by $12 million in the quarter. Its adjusted EBITDA margin also increased 350 basis points from fiscal Q1 2025, and adjusted EBITDA reached $38 million. The Hain Celestial Group, Inc. (NASDAQ:HAIN) is thus making progress across its operations.
On April 2, the company announced plans to increase access to its snack offerings by ensuring their availability at Dollar General stores. Its Garden Veggie Straws in Sea Salt appeared in Dollar General stores at the end of March, and a mass rollout to over 20,000 general stores across the country is anticipated to take place by the end of April, expanding its reach. According to billionaires, the company ranks eighth on our list of the top organic food stocks to buy.
ClearBridge Small Cap Strategy stated the following regarding The Hain Celestial Group, Inc. (NASDAQ:HAIN) in its Q3 2024 investor :
'We also added a new position inThe Hain Celestial Group, Inc. (NASDAQ:HAIN), in the consumer staples sector, which makes organic and natural products including infant formula, frozen desserts, plant-based beverages such as soy, rice and oat and frozen meat alternatives among others. Hain has seemingly been written off by the market, but new management has launched a company-wide turnaround effort that we believe will result in a more focused, profitable and growing company.'
Overall, HAIN ranks 8th on our list of best organic food stocks to buy according to billionaires. While we acknowledge the potential for HAIN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than HAIN but trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
HC Wainwright Starts Travere Therapeutics, Inc. (TVTX) at Buy on FILSPARI Breakthroughs
Travere Therapeutics, Inc. (NASDAQ:TVTX) is among the 10 Best Growth Stocks Under $100 to Buy Now. HC Wainwright & Co., a leading investment bank, has initiated a 'Buy' rating for Travere Therapeutics, Inc. (NASDAQ:TVTX), with a price target of $30, signaling an upside of around 100%. This confidence in the company underscores its position in the pharmaceutical sector. The company has just announced plans to present three new abstracts underscoring the impact of FILSPARI (sparsentan) in rare kidney disease at the International Podocyte Conference, taking place in Hamburg, Germany. The findings of FILSPARI, showcasing advanced reductions in urinary BAFF and sC5b9, along with dips in the proinflammatory and profibrotic biomarkers, signal a step forward in the treatment of IgAN. A laboratory technician working on a solution of rare diseases, housed in a cholic acid capsule. With net sales of FILSPARI increasing 182% year-over-year and the successful approval of FILSPARI in Europe and the UK, analysts have little doubt about the company's potential. Since the major revenue contribution comes from FILSPARI, the rising popularity and increasing adoption among nephrologists mean that Travere Therapeutics, Inc. (NASDAQ:TVTX) can continue to leverage a product that is quite differentiated. Travere Therapeutics, Inc. (NASDAQ:TVTX) is a biopharmaceutical company incorporated in 2008. This California-based giant recognizes, develops, and commercializes therapies for people suffering from rare kidney and metabolic diseases in the United States. While we acknowledge the potential of TVTX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Ethereum Treasury Firm SharpLink Gaming Plunges 70% – But There May Be a Twist
SharpLink Gaming (SBET), a Nasdaq-listed company that is pursuing an ether ETH treasury strategy, tumbled 70% on Thursday in after-hours trading following a fresh filing to the U.S. Securities and Exchange Commission. The company submitted an S-3ASR registration statement, enabling the resale of up to 58,699,760 shares related to its private investment in public equity (PIPE) financing. The Thursday filing allows more than 100 shareholders in the PIPE round to sell their shares, effectively flooding the market and triggering a post-close sell-off, Charles Allen, CEO of BTCS, a publicly-traded firm that's pursuing crypto reserve strategy, explained in an X post and an interview with CoinDesk. The company raised $450 million earlier this month through a PIPE round from a wide range of investors, including ConsenSys, Galaxy, and Pantera Capital, to acquire ETH for its treasury. Ethereum co-founder and ConsenSys CEO Joseph Lubin also joined the firm as board chairman. However, there may be a larger strategy behind the latest move. Allen said in an X post that he thinks the company may have quietly raised up to $1 billion to buy more ETH using an at-the-market (ATM) offering that was previously announced in a May 30 SEC filing. "If they played cards right, they would expect a surprise PR tomorrow with $1B of ETH purchases, which could light the match to reignite the stock," he said. ETH is down 4.1% over the past 24 hours at around $2,650 as bitcoin and the broader crypto markets in retrieving data Sign in to access your portfolio Error in retrieving data


Forbes
2 hours ago
- Forbes
The Chime IPO Will Kickstart A Fintech Investment Comeback
Chris Britt, co-founder and chief executive officer of Chime Financial Inc., during the company's ... More initial public offering at the Nasdaq MarketSite in New York, US, on Thursday, June 12, 2025. Chime launched its IPO with a splash. Shares jumped as much as 59% above the $27 offering price—opening at $43 and closing near $37—marking a bold public debut for the US's largest neobank. With a valuation hovering between $11.6 billion and $15 billion—well below its 2021 private peak of $25 billion—the surge raises the question: Will this trigger renewed investment in neobanks and fintech? Chime's IPO follows strong debuts from fintechs like Circle and eToro. PitchBook's Rudy Yang framed Chime as 'a strategic breakthrough—marking a return of fintech liquidity' after the sector saw VC exit values plummet from $222 billion in 2021 to under $30 billion in the past few years. Chime could be a bellwether for a neobank--and broader fintech--recovery if it: There is another side of the coin: Is Chime's IPO really a pivotal moment for the fintech industry and a validation of the digital-banking model and a template for future bank challengers? No. Chime's debut feels more like a secure base camp than a flag planted atop Everest. It suggests that public markets are open to credible fintech challengers—provided they bring scale, strong unit economics, and realistic valuations. The critical questions for neobanks: 1) Can they diversify revenue beyond interchange (loans, wealth, insurance)? 2) Will macro conditions hold stable enough to sustain IPO markets? 3) Will consumer-trust and customer growth trajectories support future public offerings? The answers are no. There are market factors impacting neobanks that have closed the door to new neobanks coming into the market: 1) Megafintechs have better economics and business models. Among consumers who consider a digital bank or neobank their primary checking account or payments provider, half of them say their primary provider is PayPal or Square Cash App. Neobanks don't just compete with incumbent banks—they compete with the megafintechs, whose platform business models give them scale and revenue diversity. 2) Interchange isn't a reliable revenue source. Relying on interchange runs against consumer behavior trends regarding: 3) The niche affinity play is tough for startups. This strategy requires neobanks to identify a segment's unique financial needs and Be the dominant affinity. Neobanks' claims of how big their affinity groups are misleading because most of us belong to multiple affinity groups. Fintech has entered a new phase—one defined by realism, consumer impact, and long-term value creation. The new phase, however, isn't about bank disruption and displacement--it's about banking industry infrastructure upgrade and replacement. The Chime IPO will help create more VC interest in fintech investment--but that investment won't go to new neobanks. Instead, it will go to startups that bring two things to the financial services industry: 1) AI-driven process reinvention from machine learning, Generative AI, and Agentic AI tools and technologies, and 2) Stablecoin and other cryptocurrency-related payments innovation. The latter may do more to disrupt banks than Chime and other neobanks have done.